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 Results and Discussion 
 PrP C Mediates Toxic Signaling of Homologous and 
Heterologous PrP Sc 
 By employing transgenic mice, it has been convinc-
ingly shown that the expression of PrP C is essential for the 
formation of PrP Sc and infectious prions  [1] . Moreover, 
neuronal PrP C is required to mediate neurotoxic effects 
of scrapie prions  [2–4] . Using a novel cell culture model, 
we could corroborate that PrP C localized at the cell sur-
face is a mediator of proapoptotic signaling induced by 
PrP Sc  [5] . This assay is based on the cocultivation of PrP C -
expressing cells with scrapie-infected cells that release 
PrP Sc and infectious prions into the cell culture medium. 
To test whether the toxic effects required sustained de 
novo formation of PrP Sc , we modified our cell culture 
model in order to minimize the possibility that propaga-
tion of infectious prions occurs. To this end, we exposed 
cells expressing hamster, human, cervid or bovine PrP C 
to mouse PrP Sc . Based on previous studies in transgenic 
mice and cell culture models  [6, 7] , it is highly unlikely 
that mouse PrP Sc can induce efficient conversion of het-
erologous PrP C molecules into PrP Sc . Strikingly, heterolo-
gous PrP C , be it of hamster, human, cervid or bovine ori-
gin, could efficiently mediate toxic signaling of mouse 
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 Abstract 
 Prion diseases in humans and animals comprise a group of 
invariably fatal neurodegenerative diseases characterized 
by the formation of a pathogenic protein conformer desig-
nated PrP Sc and infectious particles denoted prions. The cel-
lular prion protein (PrP C ) has a central role in the pathogen-
esis of prion disease. First, it is the precursor of PrP Sc and in-
fectious prions and second, its expression on neuronal cells 
is required to mediate toxic effects of prions. To specifically 
study the role of PrP C as a mediator of toxic signaling, we 
have developed novel cell culture models, including primary 
neurons prepared from PrP-deficient mice. Using these ap-
proaches we have been able to show that PrP C can interact 
with and mediate toxic signaling of various   -sheet-rich con-
formers of different origins, including amyloid   , suggesting 
a pathophysiological role of the prion protein beyond prion 
diseases.  Copyright © 2011 S. Karger AG, Basel 
 Received: June 28, 2011 
 Accepted: August 25, 2011 
 Published online: December 9, 2011 D i s e a s e s
 Jörg Tatzelt 
 Ludwig Maximilians University Munich 
 Schillerstrasse 44 
 DE–80336 Munich (Germany) 
 Tel. +49 89 2180 75442, E-Mail Joerg.Tatzelt   @   med.uni-muenchen.de 
 © 2011 S. Karger AG, Basel
1660–2854/12/0104–0298$38.00/0 
 Accessible online at:
www.karger.com/ndd 
 Cellular Prion Protein Mediates Toxic 
Signaling of Amyloid Beta  
Neurodegenerative Dis 2012;10:298–300 299
PrP Sc in our model. These findings provided experimen-
tal evidence that toxic signaling of PrP Sc via PrP C appears 
to be independent of PrP Sc propagation  [8] .
 PrP C Binds to and Mediates Toxic Signaling of 
  -Sheet-Rich Conformers of Different Origins 
 Some observations already suggested a possible con-
nection between Alzheimer’s disease and prion diseases 
 [9] , but the first mechanistic insight into a possible role of 
PrP C in amyloid beta (A  )-induced toxicity was provided 
by the Strittmatter group. They identified PrP C as a high-
affinity receptor for oligomeric conformers of A  and 
showed that expression of PrP C is required to mediate A  -
induced inhibition of long-term potentiation and memory 
impairment in transgenic Alzheimer mice  [10, 11] . Ini-
tially, these results could not be reproduced by other 
groups  [12–14] . However, in the meantime, independent 
studies, including one from our group, provided addition-
al experimental evidence for the concept that PrP C can act 
as a mediator of A  -induced toxicity  [8, 15–18] .
 In our study, we did not only focus on the role of PrP C 
as a possible mediator of A  -induced toxicity, but we also 
addressed the possibility that PrP C can mediate toxic sig-
naling of diverse   -sheet-rich conformers. In particular, 
we tested toxic assemblies formed by (a) A  peptide, (b) 
the NM domain of the yeast prion protein Sup35  [19] and 
(c) designed   -sheet peptides  [20] . Indeed, employing es-
tablished cell lines and primary neurons prepared from 
wild-type or PrP 0/0 mice, we could show that the expres-
sion of PrP C sensitizes cells to toxic effects of different 
  -sheet-rich conformers  [8] .
 The mechanisms underlying the toxic activity of   -
sheet-rich conformers are far from being understood, but 
it is conceivable that different upstream events converge 
at similar neurotoxic signaling pathways. We therefore 
started to define components downstream of PrP C in-
volved in toxic signaling. Interestingly, A  -, PrP Sc - and 
  -peptide-induced toxicity was significantly reduced by 
pharmacological blockage of N-methyl- D -aspartate re-
ceptor activity. In addition, we observed that PrP Sc can 
induce mitochondrial alterations in neurons, such as 
perinuclear clustering of mitochondria.
 Another important issue is to define domains of PrP C 
involved in signal transmission. This involves interac-
tions of PrP C with the pathogenic protein assemblies and 
with cellular factors required for signal transmission. A 
consistent finding of different groups is that the primary 
binding site of oligomeric A  lies within the intrinsical-
ly disordered N-terminal domain of PrP C . Further fine 
mapping indicated a prominent role of the region be-
tween amino acids 90 and 119  [10, 18, 21] . We could cor-
roborate that PrP  N, a mutant lacking a large portion of 
the N-terminal domain, is impaired in both binding to 
A  and mediating its toxic effects. Moreover, a secreted 
version of the N-terminal domain of PrP C efficiently in-
teracted with   -sheet-rich conformers and interfered 
with toxic signaling via PrP C . However, binding of   -
sheet-rich conformers to PrP C at the plasma membrane is 
not sufficient to induce toxic signaling. PrP-CD4, a PrP 
mutant anchored to the plasma membrane by a heterol-
ogous C-terminal transmembrane domain, binds to   -
peptides but cannot mediate toxic effects. Thus, targeting 
of PrP C to specific microdomains by a GPI anchor could 
be a prerequisite to induce intracellular signaling path-
ways, for example via Fyn kinase  [8, 22] . While there is 
increasing support for a role of PrP C as a mediator of A  -
induced synaptic dysfunction, further research is re-
quired to better characterize the toxic protein assemblies 
and to identify the underlying mechanisms disrupting 
neuronal homeostasis.
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